Inhibitors of cognitive decline

Details for Australian Patent Application No. 2010234518 (hide)

Owner Cognition Therapeutics, Inc.

Inventors Rishton, Gilbert M.; Catalano, Susan

Agent Pizzeys

Pub. Number AU-A-2010234518

PCT Pub. Number WO2010/118055

Priority 61/309,091 01.03.10 US; 61/308,667 26.02.10 US; 61/167,984 09.04.09 US

Filing date 6 April 2010

Wipo publication date 14 October 2010

International Classifications

C07D 207/04 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 36/906 (2006.01) Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines

Event Publications

19 January 2012 Section 223 Application Allowed

  Cognition Therapeutics, Inc. The time in which to enter the National Phase has been extended to 09 Dec 2011. Address for service in Australia -

2 February 2012 PCT application entered the National Phase

  PCT publication WO2010/118055 Priority application(s): WO2010/118055

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010234521-Polypeptides having cellulase activity

2010234514-Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses